Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc | Director | Common Stock | 192K | $169K | $0.88 | Jun 10, 2024 | Direct |
AMARIN CORP PLC\UK | Director | Stock Option (Right to Buy) | 224K | Jan 9, 2023 | Direct | ||
AMARIN CORP PLC\UK | Director | Restricted Stock Units | 182K | Jan 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals, Inc | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
XFOR | X4 Pharmaceuticals, Inc | Aug 9, 2023 | 2 | -$138K | 4 | Aug 11, 2023 | Interim Chief Medical Officer, Director |
AMRN | AMARIN CORP PLC\UK | Jan 9, 2023 | 2 | $0 | 4 | Jan 12, 2023 | Director |
AMRN | AMARIN CORP PLC\UK | Jan 9, 2023 | 0 | $0 | 3 | Jan 12, 2023 | Director |
XFOR | X4 Pharmaceuticals, Inc | Jun 6, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
XFOR | X4 Pharmaceuticals, Inc | Jun 2, 2021 | 1 | $57K | 4 | Jun 2, 2021 | Director |